← All trials
NCT03561909
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 17, 2018
- Primary completion
- Dec 10, 2018
- Completion date
- Dec 10, 2018
- First posted
- Jun 19, 2018
- Last posted
- May 10, 2019
- Enrollment
- 25
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Prophylix Pharma ASLead sponsor
- German Red CrossCollaborator
- FraunhoferCollaborator
- Larix A/SCollaborator
- Prophylix Pharma ASStudy chair
- Prophylix Pharma ASOfficial
- Fraunhofer-Institute of Toxicology and Experimental MedicineCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.